Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VERTEX PHARMACEUTICALS INC / MA | Director | Common Stock | 6.54K | $2.74M | $419.07 | Aug 10, 2023 | Direct |
VERTEX PHARMACEUTICALS INC / MA | Director | Stock Option (Right to Buy) | 3.14K | $256K | $81.54 | May 1, 2024 | Direct |
ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRTX | VERTEX PHARMACEUTICALS INC / MA | May 1, 2024 | 1 | $0 | 4 | May 3, 2024 | Director |
VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 10, 2023 | 3 | -$2.22M | 4 | Aug 14, 2023 | Director |
VRTX | VERTEX PHARMACEUTICALS INC / MA | May 1, 2023 | 1 | $0 | 4 | May 3, 2023 | Director |
VRTX | VERTEX PHARMACEUTICALS INC / MA | May 1, 2022 | 2 | $0 | 4 | May 3, 2022 | Director |
XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 6 | $0 | 4 | Nov 22, 2021 | Director |